拉曼光谱的临床应用提高不确定甲状腺结节的诊断准确性
这项前瞻性、盲法、单中心研究纳入123例细胞学诊断为不确定或更可疑(TIR3A、TIR3B、TIR4、TIR5)且为手术候选者的患者,对细针穿刺标本进行拉曼光谱分析,并与细胞学及最终组织学比较。拉曼光谱预测甲状腺恶性肿瘤的总体特异性为86.8%,不确定细胞学类别中特异性为86.5%。作者认为拉曼光谱是有价值的诊断工具,可作为分子研究的有效替代,改善不确定结节的管理并减少不必要手术。
要点
- 拉曼光谱预测甲状腺恶性肿瘤的总体特异性为86.8%,不确定细胞学类别中为86.5%。
- 高风险超声类别中,拉曼光谱特异性在TIR3A为87.5%,在TIR3B达100%。
- 基于拉曼光谱阳性检测,不必要手术总体降至7.4%(TIR3A为33.3%,TIR3B为6.7%)。
核心结论
- 作者认为,这是拉曼光谱首次用于甲状腺细胞学,确认其作为有价值诊断工具及分子研究有效替代的作用,能够改善不确定结节的管理并减少不必要手术。
研究设计与样本
- 前瞻性、盲法、单中心研究,纳入123例细胞学诊断为不确定或更可疑(TIR3A、TIR3B、TIR4、TIR5)且为手术候选者(由国际指南定义)的患者,对细针穿刺标本进行拉曼光谱分析,并与细胞学及最终组织学(参考标准)比较。
主要发现
- 研究人群分布为TIR3A 37例、TIR3B 32例、TIR4 16例、TIR5 38例;30.9%的患者组织学诊断为良性。
- 拉曼光谱预测细针穿刺样本中甲状腺恶性肿瘤的总体特异性为86.8%,不确定细胞学类别中特异性为86.5%。
- 高风险超声类别患者中,拉曼光谱特异性在TIR3A为87.5%,在TIR3B达100%。
- 组织学良性诊断在TIR3A患者中占72.9%,在TIR3B患者中占31.3%。
- 基于拉曼光谱阳性检测,不必要手术总体降至7.4%(TIR3A为33.3%,TIR3B为6.7%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Molecular analysis of thyroid fine-needle aspiration (FNA) specimens is believed to improve the management of indeterminate nodules. Raman spectroscopy (RS) can differentiate benign and malignant thyroid lesions in surgically removed tissues, generating distinctive structural profiles. Herein, the diagnostic performance of RS was tested on FNA biopsies of thyroid gland. DESIGN: Prospective, blinded, and single-center study. METHODS: We enrolled 123 patients with indeterminate or more ominous cytologic diagnoses (TIR3A-low-risk indeterminate lesion, TIR3B-high-risk indeterminate lesion, TIR4-suspicious of malignancy, TIR5-malignant). All subjects were surgical candidates (defined by international guidelines) and submitted to FNA procedures for RS analysis. We compared RS data, cytologic findings, and final histologic assessments (as reference standard) using various statistical techniques. RESULTS: The distribution of our study population was as follows: TIR3A:37, TIR3B:32, TIR4:16, and TIR5:38. In 30.9% of patients, histologic diagnoses were benign. For predicting thyroid malignancy in FNA samples, the overall specificity of RS was 86.8%, with 86.5% specificity in indeterminate cytologic categories. In patients with high-risk ultrasound categories, the specificity of RS increased to 87.5% for TIR3A, reaching 100% for TIR3B. Benign histologic diagnoses accounted for 72.9% of patients classified as TIR3A and 31.3% of those classified as TIR3B. Based on positive RS testing, unnecessary surgery was reduced to 7.4% overall (TIR3A-33.3%, TIR3B-6.7%). CONCLUSIONS: This premier use of RS for thyroid cytology confirms its role as a valuable diagnostic tool and a valid alternative to molecular studies, capable of improving the management of indeterminate nodules and reducing unnecessary surgery.
引用
- Palermo A, Sodo A, Naciu AM, et al. Clinical Use of Raman Spectroscopy Improves Diagnostic Accuracy for Indeterminate Thyroid Nodules. J Clin Endocrinol Metab. 2022. PMID: 36103268. doi:10.1210/clinem/dgac537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。